Aaron Wealth Advisors »

Regeneron Pharmaceuticals shares owned by Aaron Wealth Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Aaron Wealth Advisors from 13F filings

Historical chart of Aaron Wealth Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Aaron Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Aaron Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $226k 235 962.49
2023-03-31 $204k 248 821.67
2022-03-31 $127k 89k 1.43

More positions owned by Aaron Wealth Advisors

Ishares Tr Core Msci Eafe (IEFA)
Amgen (AMGN)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Ishares Core Msci Emkt (IEMG)
Flexshares Tr Mornstar Upstr (GUNR)
Proshares Tr DJ BRKFLD GLB (TOLZ)
Microsoft Corporation (MSFT)
Freeport-mcmoran CL B (FCX)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
NVIDIA Corporation (NVDA)

View all positions for Aaron Wealth Advisors

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Susquehanna International
Ubs Global Asset Management Americas
Charles Schwab Investment Management

View all funds holding Regeneron Pharmaceuticals